Biosensia awarded Horizon 2020 grant by the European Commission to develop a 15-plex diagnostic test, July 2015.

Biosensia Ltd

Biosensia are pleased to announce they have been awarded €660,000 by the European Commission, for the development of a new 15 biomarker diagnostic test. The funding was awarded as a result of a successful grant application in partnership with UK diagnostic company. The product is intended to screen individuals in developing countries for critical health markers, thereby improving their care.

2018-06-29T02:15:42+00:00 8:21 pm|RapiPlex|